These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33582479)

  • 1. Initial experience with positron emission tomography/computed tomography in addition to computed tomography and magnetic resonance imaging in preoperative risk assessment of endometrial cancer patients.
    Nordskar NJ; Hagen B; Ogarkov A; Vesterfjell EV; Salvesen Ø; Aune G
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():46-52. PubMed ID: 33582479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
    Taşkin S; Varli B; Ersöz CC; Altin D; Soydal Ç; Ortaç F
    Nucl Med Commun; 2020 Apr; 41(4):389-394. PubMed ID: 31939903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
    Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
    Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
    Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
    Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer.
    Kitajima K; Murakami K; Yamasaki E; Fukasawa I; Inaba N; Kaji Y; Sugimura K
    AJR Am J Roentgenol; 2008 Jun; 190(6):1652-8. PubMed ID: 18492920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of PET/CT in determining lymph node metastasis of endometrial cancer.
    Budak E; Yanarateş A
    Ginekol Pol; 2019; 90(10):565-570. PubMed ID: 31686412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.
    Park JY; Kim EN; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2008 Mar; 108(3):486-92. PubMed ID: 18201753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
    Stewart KI; Chasen B; Erwin W; Fleming N; Westin SN; Dioun S; Frumovitz M; Ramirez PT; Lu KH; Wong F; Aloia TA; Soliman PT
    Cancer; 2019 Oct; 125(19):3347-3353. PubMed ID: 31225906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer.
    Aşıcıoğlu O; Gungorduk K; Ozdemir A; Güngördük Ö; Gokçü M; Yaşar L; Sancı M
    J Obstet Gynaecol; 2019 Jan; 39(1):105-109. PubMed ID: 30187784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
    Nogami Y; Banno K; Irie H; Iida M; Kisu I; Masugi Y; Tanaka K; Tominaga E; Okuda S; Murakami K; Aoki D
    Jpn J Clin Oncol; 2015 Jan; 45(1):26-34. PubMed ID: 25368102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
    Tanaka T; Sasaki S; Tsuchihashi H; Terai Y; Yamamoto K; Yamada T; Ohmichi M
    Medicine (Baltimore); 2018 Apr; 97(16):e0410. PubMed ID: 29668599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
    Stecco A; Buemi F; Cassarà A; Matheoud R; Sacchetti GM; Arnulfo A; Brambilla M; Carriero A
    Radiol Med; 2016 Jul; 121(7):537-45. PubMed ID: 27033474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
    Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
    Eur Radiol; 2009 Jun; 19(6):1529-36. PubMed ID: 19184037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.